Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Melanotan-1 Tanning Complete Guide 2026: Injectable vs Implant Formulations

Subcutaneous injection (lyophilised) Self-administered, reconstituted with bacteriostatic water 7–10 days melanogenesis per dose Research suppliers only $40–80 per 10mg vial Requires reconstitution and sterile technique; no clinical oversight Scenesse implant

This comparison does not assign a generated winner or score.

  • Subcutaneous injection (lyophilised)
  • Self-administered, reconstituted with bacteriostatic water
  • 7–10 days melanogenesis per dose
  • Research suppliers only
  • $40–80 per 10mg vial
  • Requires reconstitution and sterile technique; no clinical oversight
  • Scenesse implant (afamelanotide)
  • Physician-administered, biodegradable polymer rod
  • 60 days continuous release
  • Prescription-only (FDA-approved for EPP)
  • $8,000–12,000 per implant
  • Gold standard for safety and consistency; cost prohibitive outside EPP indication
  • Nasal spray (investigational)
  • Intranasal mucoadhesive
  • Variable. Not well-characterised
  • Not commercially available
  • N/A
  • Poor bioavailability; melanin response inconsistent in trials
  • The implant formulation (Scenesse) releases 16mg afamelanotide over 60 days via a biodegradable copolymer matrix inserted subcutaneously above the hip. This eliminates the need for reconstitution, maintains stable plasma levels, and ensures pharmaceutical-grade purity. But it's only accessible to patients with EPP or those enrolled in clinical trials. Off-label prescribing for cosmetic tanning is not covered by insurance and costs $8,000+ per implant.
  • Injectable MT-1 sourced from research peptide suppliers comes as lyophilised powder requiring reconstitution with bacteriostatic water. Sterile technique is non-negotiable. Contamination during reconstitution or injection introduces infection risk that pharmaceutical implants eliminate entirely. Storage at 2–8°C is required post-reconstitution, with degradation occurring rapidly above 25°C. No batch-level purity testing or endotoxin screening occurs with research-grade peptides, meaning the advertised 10mg dose may contain significantly less active peptide or include bacterial contaminants.
More references

Related material